537 related articles for article (PubMed ID: 35313950)
1. Solving neurodegeneration: common mechanisms and strategies for new treatments.
Wareham LK; Liddelow SA; Temple S; Benowitz LI; Di Polo A; Wellington C; Goldberg JL; He Z; Duan X; Bu G; Davis AA; Shekhar K; Torre A; Chan DC; Canto-Soler MV; Flanagan JG; Subramanian P; Rossi S; Brunner T; Bovenkamp DE; Calkins DJ
Mol Neurodegener; 2022 Mar; 17(1):23. PubMed ID: 35313950
[TBL] [Abstract][Full Text] [Related]
2. [Aiming for zero blindness].
Nakazawa T
Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
[TBL] [Abstract][Full Text] [Related]
3. Widespread retina and optic nerve neuroinflammation in enucleated eyes from glaucoma patients.
Rutigliani C; Tribble JR; Hagström A; Lardner E; Jóhannesson G; Stålhammar G; Williams PA
Acta Neuropathol Commun; 2022 Aug; 10(1):118. PubMed ID: 35986368
[TBL] [Abstract][Full Text] [Related]
4. Targets of Neuroprotection in Glaucoma.
He S; Stankowska DL; Ellis DZ; Krishnamoorthy RR; Yorio T
J Ocul Pharmacol Ther; 2018; 34(1-2):85-106. PubMed ID: 28820649
[TBL] [Abstract][Full Text] [Related]
5. The Role of Neurovascular System in Neurodegenerative Diseases.
Ahmad A; Patel V; Xiao J; Khan MM
Mol Neurobiol; 2020 Nov; 57(11):4373-4393. PubMed ID: 32725516
[TBL] [Abstract][Full Text] [Related]
6. Common aspects between glaucoma and brain neurodegeneration.
Saccà SC; Paluan F; Gandolfi S; Manni G; Cutolo CA; Izzotti A
Mutat Res Rev Mutat Res; 2020; 786():108323. PubMed ID: 33339584
[TBL] [Abstract][Full Text] [Related]
7. Glaucoma and the brain: Trans-synaptic degeneration, structural change, and implications for neuroprotection.
Lawlor M; Danesh-Meyer H; Levin LA; Davagnanam I; De Vita E; Plant GT
Surv Ophthalmol; 2018; 63(3):296-306. PubMed ID: 28986311
[TBL] [Abstract][Full Text] [Related]
8. Glaucoma as a Neurodegenerative Disease Caused by Intrinsic Vulnerability Factors.
Artero-Castro A; Rodriguez-Jimenez FJ; Jendelova P; VanderWall KB; Meyer JS; Erceg S
Prog Neurobiol; 2020 Oct; 193():101817. PubMed ID: 32360241
[TBL] [Abstract][Full Text] [Related]
9. Neuroinflammation in Glaucoma and Optic Nerve Damage.
Mac Nair CE; Nickells RW
Prog Mol Biol Transl Sci; 2015; 134():343-63. PubMed ID: 26310164
[TBL] [Abstract][Full Text] [Related]
10. Glaucoma - a neurodegenerative disease with cerebral neuroconnectivity elements.
Neacșu AM; Ferechide D
Rom J Ophthalmol; 2022; 66(3):219-224. PubMed ID: 36349168
[TBL] [Abstract][Full Text] [Related]
11. Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature.
Redenšek Trampuž S; Vogrinc D; Goričar K; Dolžan V
Front Mol Neurosci; 2023; 16():1123955. PubMed ID: 37008787
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors for Retinal Ganglion Cell Distress in Glaucoma and Neuroprotective Potential Intervention.
Vernazza S; Oddone F; Tirendi S; Bassi AM
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360760
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotection in Glaucoma: Animal Models and Clinical Trials.
Almasieh M; Levin LA
Annu Rev Vis Sci; 2017 Sep; 3():91-120. PubMed ID: 28731838
[TBL] [Abstract][Full Text] [Related]
14. The Role of Sigma 1 Receptor as a Neuroprotective Target in Glaucoma.
Mysona B; Kansara N; Zhao J; Bollinger K
Adv Exp Med Biol; 2017; 964():299-307. PubMed ID: 28315279
[TBL] [Abstract][Full Text] [Related]
15. [Recent Research Efforts to Achieve Neuroprotection, Progression and Treatment of Glaucoma].
Jacobi A; van Zyl T
Klin Monbl Augenheilkd; 2020 Feb; 237(2):133-139. PubMed ID: 32040976
[TBL] [Abstract][Full Text] [Related]
16. Glaucoma as a neurodegenerative disease.
Danesh-Meyer HV; Levin LA
J Neuroophthalmol; 2015 Sep; 35 Suppl 1():S22-8. PubMed ID: 26274833
[TBL] [Abstract][Full Text] [Related]
17. Axonal degeneration and regeneration: a mechanistic tug-of-war.
Hilliard MA
J Neurochem; 2009 Jan; 108(1):23-32. PubMed ID: 19054282
[TBL] [Abstract][Full Text] [Related]
18. Transgenic inhibition of astroglial NF-κB restrains the neuroinflammatory and neurodegenerative outcomes of experimental mouse glaucoma.
Yang X; Zeng Q; Barış M; Tezel G
J Neuroinflammation; 2020 Aug; 17(1):252. PubMed ID: 32859212
[TBL] [Abstract][Full Text] [Related]
19. Constitutively active STING causes neuroinflammation and degeneration of dopaminergic neurons in mice.
Szego EM; Malz L; Bernhardt N; Rösen-Wolff A; Falkenburger BH; Luksch H
Elife; 2022 Oct; 11():. PubMed ID: 36314770
[TBL] [Abstract][Full Text] [Related]
20. Shared Molecular Pathways in Glaucoma and Other Neurodegenerative Diseases: Insights from RNA-Seq Analysis and miRNA Regulation for Promising Therapeutic Avenues.
Vasconcelos CFM; Ribas VT; Petrs-Silva H
Cells; 2023 Aug; 12(17):. PubMed ID: 37681887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
